Pursuant to Regulation 29 of the Listing Regulations, Ajanta Pharma has informed that a Meeting of the Board of Directors of the Company will be held on Wednesday, 1st February 2023 to consider and take on record unaudited consolidated & standalone financial results of the Company for the third quarter and nine months ended 31st December 2022.
The above information is a part of company’s filings submitted to BSE.